Suppr超能文献

评估抗高血压药物疗效特征时,平滑指数、谷峰比值和晨峰比值的比较

Comparison of the smoothness index, the trough : peak ratio and the morning : evening ratio in assessing the features of the antihypertensive drug effect.

作者信息

Stergiou George S, Efstathiou Stamatis P, Skeva Irini I, Baibas Nikolaos M, Roussias Leonidas G, Mountokalakis Theodore D

机构信息

Third University Deparment of Medicine, Sotiria Hospital, Athens, Greec.

出版信息

J Hypertens. 2003 May;21(5):913-20. doi: 10.1097/01.hjh.0000059017.82022.83.

Abstract

OBJECTIVE

To provide a direct comparison of the trough : peak ratio (TPR), the morning : evening home blood pressure ratio (MER) and the smoothness index (SI) in assessing the features of the antihypertensive drug effect.

PATIENTS AND METHODS

A total of 27 untreated hypertensives were randomized to receive lisinopril 20 mg o.d. or losartan 50 mg o.d. for 5 weeks and were subsequently crossed-over to the alternative treatment for a second 5-week period. Twenty-four hour ambulatory and 5-day home blood pressure were monitored before randomization and at the end of each treatment period. TPR, MER and SI were calculated for each drug for the total study population and for responders only.

RESULTS

When all patients were considered, lisinopril provided higher values of TPR [0.63/0.66 for systolic/diastolic blood pressure (SBP/DBP)], MER (1.02/0.77) and SI (1.01/0.87) than losartan (0.35/0.51, 0.60/0.60 and 0.64/0.53, respectively). Analysis of responders only, again showed a clear advantage of lisinopril over losartan in TPR (0.77/0.67 versus 0.44/0.47, respectively) and MER (0.86/0.87 versus 0.48/0.61), whereas there was no difference in SI (1.25/1.13 for lisinopril versus 1.11/1.12 for losartan).

CONCLUSIONS

These data suggest that the assessment of the duration of the antihypertensive drug effect provided by the MER is consistent to that by the TPR and that two drugs with different levels of TPR and MER may have the same level of SI. It appears that the SI is not simply a more reliable index of the features of the antihypertensive drug effect, but offers a different type of information complementary to that provided by the TPR and the MER, in regard to the homogeneity and the magnitude but not the duration of the antihypertensive effect.

摘要

目的

直接比较谷峰比值(TPR)、早晚家庭血压比值(MER)和平滑指数(SI)在评估降压药物疗效特征方面的情况。

患者与方法

总共27例未经治疗的高血压患者被随机分为两组,一组每天口服20毫克赖诺普利,另一组每天口服50毫克氯沙坦,为期5周,随后交叉接受另一组治疗,为期5周。在随机分组前以及每个治疗期结束时监测24小时动态血压和5天家庭血压。计算每种药物在整个研究人群以及仅在有反应者中的TPR、MER和SI。

结果

当考虑所有患者时,赖诺普利的TPR [收缩压/舒张压(SBP/DBP)分别为0.63/0.66]、MER(1.02/0.77)和SI(1.01/0.87)均高于氯沙坦(分别为0.35/0.51、0.60/0.60和0.64/0.53)。仅对有反应者进行分析时,赖诺普利在TPR(分别为0.77/0.67与0.44/0.47)和MER(0.86/0.87与0.48/0.61)方面仍明显优于氯沙坦,而SI方面无差异(赖诺普利为1.25/1.13,氯沙坦为1.11/1.12)。

结论

这些数据表明,MER对降压药物疗效持续时间的评估与TPR一致,且两种TPR和MER水平不同的药物可能具有相同水平的SI。似乎SI并非仅仅是评估降压药物疗效特征的更可靠指标,而是在降压效果的均匀性和幅度而非持续时间方面,提供了与TPR和MER不同类型的补充信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验